These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20684689)

  • 61. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost-benefit analysis.
    Okafor CE; Ekwunife OI
    Lancet Glob Health; 2021 Aug; 9(8):e1088-e1100. PubMed ID: 34297961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
    Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
    Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
    Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
    Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.
    Standaert B; Parez N; Tehard B; Colin X; Detournay B
    Appl Health Econ Health Policy; 2008; 6(4):199-216. PubMed ID: 19382820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
    Niyibitegeka F; Riewpaiboon A; Youngkong S; Thavorncharoensap M
    Vaccine; 2021 Feb; 39(8):1272-1282. PubMed ID: 33487467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
    Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
    Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand.
    Rochanathimoke O; Riewpaiboon A; Praditsitthikorn N; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):811-819. PubMed ID: 34008471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J; Van Damme P; Beutels P
    Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.
    Rozenbaum MH; Mangen MJ; Giaquinto C; Wilschut JC; Hak E; Postma MJ;
    BMC Public Health; 2011 Jun; 11():462. PubMed ID: 21663620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs.
    Wang J; Zhang H; Zhang H; Fang H
    Hum Vaccin Immunother; 2022 Dec; 18(7):2090162. PubMed ID: 35816415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
    Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
    Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines.
    Luna-Casas G; Juliao P; Carreño-Manjarrez R; Castañeda-Prado A; Cervantes-Apolinar MY; Navarro-Rodriguez R; Sánchez-González G; Cortés-Alcalá R; DeAntonio R
    Hum Vaccin Immunother; 2019; 15(6):1251-1259. PubMed ID: 30380975
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.